cancer immunotherapy

Delhi, Dec. 09, 2021 (GLOBE NEWSWIRE) -- Global TIGIT Inhibitor Drug Opportunity & Clinical Research Insight 2022 Report Highlights: Global TIGIT Inhibitor Market DynamicsClinical…

Unfortunately, few people benefit from the most common form of immunotherapy, called immune checkpoint inhibitors, and scientists are actively seeking new and safe molecules called…

LUND, Sweden, July 19, 2021 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems AB (publ) (CLS), developer of high precision, image-guided focal laser ablation systems, today announced that…